Delivery Order SPE2DB22D3401-SPE2DB23FT4SY

Award Date 8/18/23
Potential Completion Date 8/21/23
Potential Value $7.5K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to deliver Ferumoxytol 510 mg/17 ml vial medication. The $10,892.08 firm fixed price delivery order has a completion date of January 2, 2024. Amerisourcebergen Drug Corp, as the prime contractor, will provide these pharmaceutical products from its corporate office location in Conshohocken, Pennsylvania. This award is not associated with any...
The Defense Logistics Agency awarded a $8,355.81 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562102401 FERAHEME 510 MG/17 ML VIAL 17ML. The contract has a period of performance from September 8-11, 2023, with place of performance in Conshohocken, Pennsylvania. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will deliver the pharmaceutical products to the Defense Logistics Agency in support of its mission to provide...
The Defense Logistics Agency awarded a $8,348.94 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562158471 FERUMOXYTOL 510 MG/17 ML VIAL 17ML. The place of performance is Conshohocken, Pennsylvania. The period of performance is September 13-14, 2023. DLA will provide funding for this contract to deliver pharmaceutical products in support of Department of Defense requirements. No set aside designation or subcontractors were identified. This delivery order was issued...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Ferumoxytol 510 mg/17 ml vials. The contract, awarded by the Defense Logistics Agency (DLA), is a Firm Fixed Price Delivery Order with a ceiling value of $3,351.60 and a period of performance through February 21, 2025. This contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,793.00, is for the delivery of FERUMOXYTOL 510 MG/17 ML VIAL 17ML, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 24, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
This federal contract award, valued at $5,540.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Ferumoxytol 510 mg/17 ml vials, a pharmaceutical product used in medical treatment. The contract is a Firm Fixed Price Delivery Order with a completion date of July 17, 2023. No set-aside designation was used for this award. Amerisourcebergen Drug Corp is a major pharmaceutical...
The Defense Logistics Agency awarded a $12,824.88 firm fixed price delivery order to Amerisourcebergen Drug Corporation for INJECTAFER 750 MG/15 ML VIAL 15ML pharmaceutical products. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the specified injectable iron products to a location in Conshohocken, Pennsylvania by September 7, 2023 to support the Defense Logistics Agency's medical supply needs. The parent company, Amerisourcebergen Corporation, will oversee...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,553.46, is a Delivery Order for the supply of FERUMOXYTOL 510 MG/17 ML VIAL 17ML. It is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a seventeen dollar firm fixed price delivery order against an unspecified government-wide acquisition contract vehicle. The delivery order is with the Defense Logistics Agency to supply 1000 FEROSUL 325 MG tablets to a location in Conshohocken, Pennsylvania. The order is for product delivery by October 19, 2023 and was awarded on October 18, 2023 without a set-aside designation. As the Defense...
The Defense Logistics Agency awarded a $362,890 firm fixed price delivery order to Amerisourcebergen Drug Corporation for pharmaceutical products. Under this order, Amerisourcebergen will provide approximately sixteen fluid ounce amber vials of a proprietary one-time use pharmaceutical to the Defense Logistics Agency by August 7, 2023. The products will be delivered to Amerisourcebergen's facility in Conshohocken, Pennsylvania. No subcontractors or set aside designations were identified. This...
  • SPE2DB22D3401
    Indefinite Delivery Contract
  • SPE2DB22D3401-SPE2DB23FT4SY
    Delivery Order

The Defense Logistics Agency awarded a $7,488.25 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561866941 ferumoxytol 510 mg/17 ml vials. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by August 21, 2023 under the contract start and end dates. The Defense Logistics Agency functions to support the resupply needs of the U.S. military and this contract likely aims to fulfill medical material requirements for DOD components. No set aside designations or major subcontractors were indicated.

Generated 12/19/23, 5:40 AM